Boardman, United States
Aura Genetics is a molecular diagnostics laboratory, founded in 2022, with a focus on revolutionizing healthcare through advanced testing methods. The company's slogan, "Molecular diagnostics reference laboratory," underscores its commitment to delivering precision and accuracy in diagnostics. Currently, Aura Genetics specializes in offering PGx testing and Covid testing, catering to the critical needs of the healthcare industry.
Operating in the Health Care sector, Aura Genetics is positioned at the forefront of technological advancements driving the future of medical diagnostics. With its headquarter based in the United States, the company benefits from the vibrant ecosystem and resources available in the country's healthcare and technology sectors.
While specific details about the last investment and the associated investors are currently unavailable, Aura Genetics' innovative approach and strategic positioning within the molecular diagnostics market make it a compelling prospect for potential venture capital investment. As the company continues to develop and expand its testing capabilities, opportunities may arise for strategic partnerships and investments, enabling Aura Genetics to further solidify its position as a leader in molecular diagnostics.
